Navigation Links
Chief Technology Officer Joins ACAMP
Date:9/22/2008

EDMONTON, AB, Sept. 22 /PRNewswire/ - ACAMP Alberta Centre for Advanced MNT (Microsystems and Nanotechnology) Products is pleased to announce the appointment of Dr. Kevin Yallup as Chief Technology Officer. In this new role Dr. Yallup will lead the product development effort within ACAMP to build a world-class capability in Alberta for the packaging and assembly of micro- and nano-scale technology devices, turning them into market-ready commercial or industrial products and applications.

"We are very pleased Kevin joined our team", said Ken Brizel CEO ACAMP, "Kevin brings over 15 years experience in MNT product development from Europe to Alberta. In this role, Kevin will lead the ACAMP engineering team in supporting companies producing MNT products, through consultation, hands on design and development of state of the art packaging and assembly technologies."

Dr. Yallup has been a key contributor and the project leader on the original study in the development of ACAMP. Dr. Yallup has a broad engineering experience in MNT products, prior to joining ACAMP, he has held engineering management roles in Technology for Industry Ltd., CDT Ltd., Kymata Ltd., BCO Technologies (NI) Ltd., National Semiconductor and Analog Devices. Dr Yallup graduated from Cambridge University, UK with a degree in Natural Sciences, specializing in solid state physics.

"I am extremely excited to join ACAMP in this new role and eager to help shorten the path to commercialization for MNT companies." said Dr. Kevin Yallup, CTO ACAMP," Product development, packaging and assembly of MNT products are my focus supporting companies throughout the region."

Yallup's initial focus will be to provide practical industrial engineering support, purchase specific equipment and hire and help train the engineers needed to complete the team. ACAMP has established a class 1000 clean room, wet lab, metrology and test lab. State of the art assembly and packaging equipment is being put in place over the remainder of 2008 and beginning of 2009 including laser dicing, probers, gluing stations, Flip-Chip bonding and a host of test and reliability equipment which will facilitate the challenge of packaging micro and nano-products for prototyping and volume production for applications in energy, biomedical, agriculture, the environment, and information and communications technology.

ACAMP is the result of a collaborative effort between industry, government and academia to create a path to commercialization for established firms, small start-up companies and researchers in the microsystems and nanotechnology (MNT) sector. ACAMP is a not-for-profit company that provides support in three critical areas of commercialization: marketing & business development, product development and packaging and assembly.


'/>"/>
SOURCE ACAMP
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
2. Algenol Biofuels Appoints Chief Science Officer
3. Anesiva Announces Appointment of William Houghton, M.D. as Senior Vice President and Chief Medical Officer
4. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
5. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
6. RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer
7. Arno Therapeutics Announces Appointment of Brian Lenz, CPA as Chief Financial Officer
8. Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance
9. Pollogen Announces Appointment of Ms. Yfat Scialom as Chief Executive Officer
10. Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
11. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... ... October 10, 2017 , ... For the second ... a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled to Washington, ... from US2020. , US2020’s mission is to change the trajectory of STEM education ...
(Date:10/10/2017)... SANTA CRUZ, Calif. , Oct. 10, 2017 /PRNewswire/ ... SBIR grant from the NIH to develop RealSeq®-SC (Single ... preparation kit for profiling small RNAs (including microRNAs) from ... Cell Analysis Program highlights the need to accelerate development ... "New techniques for ...
Breaking Biology Technology:
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
(Date:3/27/2017)... N.Y. , March 27, 2017  Catholic ... Information and Management Systems Society (HIMSS) Analytics for ... EMR Adoption Model sm . In addition, CHS ... of U.S. hospitals using an electronic medical record ... for its high level of EMR usage in ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):